Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis.
about
Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosisO-glycan variability of egg-jelly mucins from Xenopus laevis: characterization of four phenotypes that differ by the terminal glycosylation of their mucins.Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo.Airway remodelling in children with cystic fibrosis.DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor.Pseudomonas aeruginosa binds to neoglycoconjugates bearing mucin carbohydrate determinants and predominantly to sialyl-Lewis x conjugates.Species differences in the physical and transport properties of airway secretions.Mucins secreted by a transformed cell line derived from human tracheal gland cells.Interactions between glycoconjugates from human respiratory airways and Pseudomonas aeruginosa.Secretory proteins and glycoconjugates synthesized by human tracheal gland cells in culture.Extracellular enzyme profiling of Stenotrophomonas maltophilia clinical isolatesMucins in airway secretions from healthy and chronic bronchitic subjects.Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis.Effect of chondroitinase ABC on purulent sputum from cystic fibrosis and other patients.Endothelial activation and increased heparan sulfate expression in cystic fibrosis.Hypertonic saline in treatment of pulmonary disease in cystic fibrosis
P2860
Q28305590-3E671631-381C-462C-8028-D180D35A1706Q30620011-7DE9E1E7-7C64-41AF-A210-F9BE8050E77AQ34058642-8DCABF57-AB4C-4903-9A6E-1E49DE67C5FEQ36169103-69068A42-C73B-4D76-B5F8-0B803CD6CA51Q38307876-BD42DD16-19CB-4164-A51E-B302D77BD29AQ38322814-F7FD0FD7-F41A-4148-BB78-053FBE71E8A1Q40451753-25473D06-147C-4A66-8A66-190CAC77E810Q41091499-D0238D15-E593-4DAF-AB6A-80495170EB0BQ41171871-9B0F0D2D-C6C5-4110-9B6B-8589901CF911Q42122242-00730168-E47B-40EE-A522-E0D8875F6562Q42408797-3E026841-AF81-4630-B084-53AD61A7FDF7Q42980641-525A9D10-ABEC-4CC3-A775-6D3E5220DA82Q43244889-A886708E-59A2-4AF6-A6D9-8E8B2E2BEAEDQ44337075-1276ECC9-4DB1-4531-9AAA-4F06001C4068Q47774987-15EC60AC-7EAE-4AC1-90C8-F29D515F451BQ58914917-5BFDE1C4-C208-4757-ADF7-984AB303D116
P2860
Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis.
@en
Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis.
@nl
type
label
Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis.
@en
Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis.
@nl
prefLabel
Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis.
@en
Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis.
@nl
P2093
P2860
P356
P1476
Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis.
@en
P2093
P2860
P304
P356
10.1165/AJRCMB/5.4.315
P577
1991-10-01T00:00:00Z